Yahoo
OTC Markets OTCPK - Delayed Quote USD

Shionogi & Co., Ltd. (SGIOY)

9.53 +0.01 (+0.11%)
As of 12:44:33 PM EST. Market Open.
Chart Range Bar
Loading chart for SGIOY
  • Previous Close 9.52
  • Open 9.55
  • Bid 9.52 x 486000
  • Ask 9.56 x 460000
  • Day's Range 9.53 - 9.55
  • 52 Week Range 8.11 - 12.00
  • Volume 154
  • Avg. Volume 121,545
  • Market Cap (intraday) 16.223B
  • Beta (5Y Monthly) 0.10
  • PE Ratio (TTM) 10.59
  • EPS (TTM) 0.90
  • Earnings Date --
  • Forward Dividend & Yield 0.22 (2.35%)
  • 1y Target Est 12.30
  • Zacks Rating Bullish

Shionogi & Co., Ltd. engages in the research, development, manufacture, and distribution of pharmaceuticals, diagnostic reagents, and medical devices in Japan and internationally. It is also involved in consumer healthcare business; manufacturing, sale, analytical testing, and pharmaceutical engineering of medicinal drugs and investigational drugs; contracted monitoring of epidemiological components in sewage; promotion of implementation in social infrastructure; and business related to providing data and information; develops and sells foothold; and research and development of mucosal vaccines. In addition, the company provides contract support services for experimental research; contract testing of agricultural production materials; solutions for education and healthcare, system development, human resource development, and training business; marketing support services; and IT services for medical and healthcare-related issues. The company was formerly known as Shionogi Shoten Co., Ltd. and changed its name to Shionogi & Co., Ltd. in 1943. The company was founded in 1878 and is headquartered in Kita, Japan.

www.shionogi.com

6,223

Full Time Employees

March 31

Fiscal Year Ends

Healthcare

Sector

Recent News

View More

Performance Overview

Trailing total returns as of 11/2/2026, which may include dividends or other distributions. Benchmark is Nikkei 225 (^N225) .

YTD Return

SGIOY
5.77%
Nikkei 225 (^N225)
25.31%

1-Year Return

SGIOY
15.38%
Nikkei 225 (^N225)
20.36%

3-Year Return

SGIOY
22.56%
Nikkei 225 (^N225)
97.44%

5-Year Return

SGIOY
11.41%
Nikkei 225 (^N225)
113.69%

Earnings Trends

View More

Earnings Per Share

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q2 FY27
Revenue 187.07B
Earnings 21.85B
Profit Margin 11.68%

Q3

FY26

Q4

FY26

Q1

FY27

Q2

FY27

0
50B
100B
150B
20.0%
30.0%
40.0%
50.0%

Analyst Insights

View More

Analyst Price Targets

12.30
12.30 Average
9.53 Current
12.30 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    37.94%

  • Return on Assets (ttm)

    3.48%

  • Return on Equity (ttm)

    15.22%

  • Revenue (ttm)

    637.09B

  • Net Income Avi to Common (ttm)

    241.71B

  • Diluted EPS (ttm)

    0.90

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    376.48B

  • Total Debt/Equity (mrq)

    39.10%

  • Levered Free Cash Flow (ttm)

    82B

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: